User profiles for Lise J. Estcourt
Lise EstcourtAssociate Professor University of Oxford Verified email at nhsbt.nhs.uk Cited by 14421 |
Hyperimmune immunoglobulin for people with COVID‐19
…, Z McQuilten, C So-Osman, LJ Estcourt… - Cochrane Database …, 2023 - cochranelibrary.com
Background Hyperimmune immunoglobulin (hIVIG) contains polyclonal antibodies, which
can be prepared from large amounts of pooled convalescent plasma or prepared from animal …
can be prepared from large amounts of pooled convalescent plasma or prepared from animal …
Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: a living systematic review
…, Z McQuilten, C So-Osman, LJ Estcourt… - Cochrane Database …, 2021 - cochranelibrary.com
Background Convalescent plasma and hyperimmune immunoglobulin may reduce mortality
in patients with viral respiratory diseases, and are being investigated as potential therapies …
in patients with viral respiratory diseases, and are being investigated as potential therapies …
SARS‐CoV‐2‐neutralising monoclonal antibodies for treatment of COVID‐19
Background Monoclonal antibodies (mAbs) are laboratory‐produced molecules derived
from the B cells of an infected host. They are being investigated as a potential therapy for …
from the B cells of an infected host. They are being investigated as a potential therapy for …
Interleukin-6 receptor antagonists in critically ill patients with Covid-19–preliminary report
Background The efficacy of interleukin-6 receptor antagonists in critically ill patients with
coronavirus disease 2019 (Covid-19) is unclear. Methods We evaluated tocilizumab and …
coronavirus disease 2019 (Covid-19) is unclear. Methods We evaluated tocilizumab and …
[HTML][HTML] A no-prophylaxis platelet-transfusion strategy for hematologic cancers
SJ Stanworth, LJ Estcourt, G Powter… - … England Journal of …, 2013 - Mass Medical Soc
Background The effectiveness of platelet transfusions to prevent bleeding in patients with
hematologic cancers remains unclear. This trial assessed whether a policy of not giving …
hematologic cancers remains unclear. This trial assessed whether a policy of not giving …
Clinical practice guidelines from the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 convalescent plasma
Description: Coronavirus disease 2019 convalescent plasma (CCP) has emerged as a potential
treatment of COVID-19. However, meta-analysis data and recommendations are limited. …
treatment of COVID-19. However, meta-analysis data and recommendations are limited. …
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
…, M De Jong, MA Detry, EJ Duffy, LJ Estcourt… - Intensive care …, 2021 - Springer
Purpose To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill
patients with coronavirus disease 2019 (COVID-19). Methods Critically ill adults with COVID-19 …
patients with coronavirus disease 2019 (COVID-19). Methods Critically ill adults with COVID-19 …
Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials
…, CC Dungog, O Erinoso, IMS Escasa, LJ Estcourt… - BMC infectious …, 2021 - Springer
Background Convalescent plasma has been widely used to treat COVID-19 and is under
investigation in numerous randomized clinical trials, but results are publicly available only for a …
investigation in numerous randomized clinical trials, but results are publicly available only for a …
Desmopressin use for minimising perioperative allogeneic blood transfusion
M Desborough, LJ Estcourt, C Doree… - Cochrane Database …, 2004 - cochranelibrary.com
Background Public concerns regarding the safety of blood have prompted reconsideration
of the use of allogeneic blood (blood from an unrelated donor) transfusion and a range of …
of the use of allogeneic blood (blood from an unrelated donor) transfusion and a range of …
Granulocyte transfusions for treating infections in people with neutropenia or neutrophil dysfunction
LJ Estcourt, SJ Stanworth, S Hopewell… - Cochrane Database …, 2016 - cochranelibrary.com
Background Despite modern antimicrobials and supportive therapy bacterial and fungal
infections are still major complications in people with prolonged disease‐related or treatment‐…
infections are still major complications in people with prolonged disease‐related or treatment‐…